Daniela Guzmán-Uribe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Guzmán-Uribe has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Gabriel Alejandro Martínez-Castañón
Universidad Autónoma de San Luis Potosí
3 shared publications - Nereyda Niño-Martínez
Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico
3 shared publications - Facundo Ruiz
Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico
2 shared publications - Arturo Garrocho-Rangel
Endodontics Postgraduate Programme, Faculty of Dentistry, University of San Luis Potosí, San Luis Potosí, México
1 shared publication - Emmanuel Jose Gutierrez Castañeda
Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico
1 shared publication - Facundo Ruiz
Facultad de Ciencias, Universidad Autónoma de San Luis Potosí, San Luis Potosi C. P. 78295, Mexico
1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by MDPI AG in Future Pharmacology
- Vol. 6 (3) , 41
Antimicrobial Evaluation of a Novel Antibiotic Nanopaste in Dental Pulp Therapy
Background/Objectives. The use of antibiotic pastes in the Lesion Sterilization Tissue Repair (LSTR) technique has increased due to their ability to disinfect necrotic primary teeth without mechanical instrumentation. Tri-antibiotic mixtures (TAP) and Chloramphenicol-Tetracycline-Zinc Oxide (CTZ) paste remain the most common options, although their composition and dosing lack standardization. Evidence indicates that silver and zinc oxide nanoparticles enhance antimicrobial performance by disrupting biofilms and modulating inflammatory pathways, suggesting potential benefits when incorporated into intracanal medications. This study aimed to evaluate the antimicrobial activity of a chloramphenicol–tetracycline paste modified with silver nanoparticles (SNPs) and zinc oxide nanoparticles (ZnONPs) against wild Enterococcus faecalis, comparing its MIC, MBC, and inhibition zones with those of a commercial CTZ paste. Methods. SNPs and ZnONPs (1 × 10−2 M) were synthesized and characterized using UV–Vis spectroscopy and dynamic light scattering (DLS). Two antibiotic pastes (1%) were formulated, including a nanoparticle-modified version with a 4% reduction in antibiotic content. Commercial CTZ paste was prepared according to the manufacturer’s instructions. Wild E. faecalis strains were isolated from necrotic primary teeth (N = 30). MIC, MBC, and inhibition zones were determined using microdilution and Kirby–Bauer assays. Results. AB Paste and Nanopaste showed larger inhibition zones (ZOI) than the other formulations (p < 0.001). MIC and MBC analyses showed no significant differences among antibiotic formulations and SNPs (p > 0.05). Conclusions. Both the nanoparticle-free antibiotic paste and the nanoparticle-modified paste demonstrated greater inhibitory activity than commercial pastes and Nanoparticles. Despite containing 4% less antibiotics, the Nanopaste showed equivalent efficacy, indicating that reducing the drug content does not compromise antimicrobial performance and that SNPs contribute to this effect.
- 29 July 2026
- Published by MDPI AG in Future Pharmacology
- Vol. 6 (3) , 41
Open AccessAntimicrobial Evaluation of a Novel Antibiotic Nanopaste in Dental Pulp Therapy
Background/Objectives. The use of antibiotic pastes in the Lesion Sterilization Tissue Repair (LSTR) technique has increased due to their ability to disinfect necrotic primary teeth without mechanical instrumentation. Tri-antibiotic mixtures (TAP) and Chloramphenicol-Tetracycline-Zinc Oxide (CTZ) paste remain the most common options, although their composition and dosing lack standardization. Evidence indicates that silver and zinc oxide nanoparticles enhance antimicrobial performance by disrupting biofilms and modulating inflammatory pathways, suggesting potential benefits when incorporated into intracanal medications. This study aimed to evaluate the antimicrobial activity of a chloramphenicol–tetracycline paste modified with silver nanoparticles (SNPs) and zinc oxide nanoparticles (ZnONPs) against wild Enterococcus faecalis, comparing its MIC, MBC, and inhibition zones with those of a commercial CTZ paste. Methods. SNPs and ZnONPs (1 × 10−2 M) were synthesized and characterized using UV–Vis spectroscopy and dynamic light scattering (DLS). Two antibiotic pastes (1%) were formulated, including a nanoparticle-modified version with a 4% reduction in antibiotic content. Commercial CTZ paste was prepared according to the manufacturer’s instructions. Wild E. faecalis strains were isolated from necrotic primary teeth (N = 30). MIC, MBC, and inhibition zones were determined using microdilution and Kirby–Bauer assays. Results. AB Paste and Nanopaste showed larger inhibition zones (ZOI) than the other formulations (p < 0.001). MIC and MBC analyses showed no significant differences among antibiotic formulations and SNPs (p > 0.05). Conclusions. Both the nanoparticle-free antibiotic paste and the nanoparticle-modified paste demonstrated greater inhibitory activity than commercial pastes and Nanoparticles. Despite containing 4% less antibiotics, the Nanopaste showed equivalent efficacy, indicating that reducing the drug content does not compromise antimicrobial performance and that SNPs contribute to this effect.
- Open Access
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 44880
Development of a nano antibiotic paste for lesion sterilization and tissue repair technique in pediatric dentistry
This is an in vitro study aimed to develop a nano-antibiotic paste containing chloramphenicol, tetracycline, and silver and zinc oxide nanoparticles, evaluating its microbiological efficacy against four bacterial strains, determining its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against a commercial CTZ paste. Silver and zinc oxide nanoparticles (1 × 10− 2 M) were synthesized and characterized by UV-Vis and DLS. A paste of tetracycline and chloramphenicol was prepared to a known concentration (10%), adding the synthesized nanoparticles and reducing the antibiotic percentage from the original proportions (− 4%). The commercial CTZ paste was then prepared following the manufacturer’s instructions (13% concentration). Microdilution method and Kirby-Bauer assessment were used at three different concentrations to evaluate antimicrobial activity for both pastes against Enterococcus faecalis, Staphylococcus aureus, Streptococcus mutans, and Escherichia coli. MBC for the nano antibiotic paste (10%) and commercial CTZ paste (13%) were 4.8 µg/ml and 12 µg/ml for S. aureus, 19.5 µg/ml and 12.8 µg/ml for E. coli, 19.5 µg/ml and 12.8 µg/ml for E. faecalis, 39 µg/ml and 25 µg/ml for S. mutans, respectively. For Kirby Bauer statistical difference was shown, favoring nano paste for C1 E. coli (p = 0.000262) and C2 E. coli (p = 0.000388), and for C3 S. mutans (p = 0.00749), and commercial CTZ paste, for C2 S. aureus (p = 0.0146) and C2 E. faecalis (p = 0.00033). Microbiological assays revealed that the commercial CTZ de Mexico™ paste (13%) exhibited superior bactericidal activity, with lower MBCs, than the Nano formulation (10%) containing 4% less antibiotic. Results offer in vitro doses for the strains.
- 29 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 44880
Open AccessDevelopment of a nano antibiotic paste for lesion sterilization and tissue repair technique in pediatric dentistry
This is an in vitro study aimed to develop a nano-antibiotic paste containing chloramphenicol, tetracycline, and silver and zinc oxide nanoparticles, evaluating its microbiological efficacy against four bacterial strains, determining its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against a commercial CTZ paste. Silver and zinc oxide nanoparticles (1 × 10− 2 M) were synthesized and characterized by UV-Vis and DLS. A paste of tetracycline and chloramphenicol was prepared to a known concentration (10%), adding the synthesized nanoparticles and reducing the antibiotic percentage from the original proportions (− 4%). The commercial CTZ paste was then prepared following the manufacturer’s instructions (13% concentration). Microdilution method and Kirby-Bauer assessment were used at three different concentrations to evaluate antimicrobial activity for both pastes against Enterococcus faecalis, Staphylococcus aureus, Streptococcus mutans, and Escherichia coli. MBC for the nano antibiotic paste (10%) and commercial CTZ paste (13%) were 4.8 µg/ml and 12 µg/ml for S. aureus, 19.5 µg/ml and 12.8 µg/ml for E. coli, 19.5 µg/ml and 12.8 µg/ml for E. faecalis, 39 µg/ml and 25 µg/ml for S. mutans, respectively. For Kirby Bauer statistical difference was shown, favoring nano paste for C1 E. coli (p = 0.000262) and C2 E. coli (p = 0.000388), and for C3 S. mutans (p = 0.00749), and commercial CTZ paste, for C2 S. aureus (p = 0.0146) and C2 E. faecalis (p = 0.00033). Microbiological assays revealed that the commercial CTZ de Mexico™ paste (13%) exhibited superior bactericidal activity, with lower MBCs, than the Nano formulation (10%) containing 4% less antibiotic. Results offer in vitro doses for the strains.
- 10 November 2025
- Published by Springer Nature in MRS Communications
- Vol. 15 (6) , 1220-1228
Poly(lactic acid) surface modified with silver nanoparticles: Thermal, roughness, and antimicrobial evaluation
- 10 November 2025
- Published by Springer Nature in MRS Communications
- Vol. 15 (6) , 1220-1228
Poly(lactic acid) surface modified with silver nanoparticles: Thermal, roughness, and antimicrobial evaluation
- Open Access
- 11 July 2025
- Published by Universidad de Costa Rica in Odovtos - International Journal of Dental Sciences
- Vol. 1 (1)
Evaluation of Dental Caries Experience and Biofilm Accumulation in Mexican Pediatric Patients with Autism Spectrum Disorder (ADS): A Cross-Sectional Study
Autism Spectrum Disorder (ASD) presents sensory and behavioral challenges that may complicate oral care. This study evaluated biofilm accumulation and caries prevalence in children with and without ASD, enrolled in an educational center in San Luis Potosí, México. A cross-sectional study was conducted at a specialized ASD educational center in San Luis Potosí, México. Twenty children with ASD and 40 neurotypical children, matched by age and sex, underwent oral examinations assessing biofilm using the simplified debris index (DI-S) and caries using the international caries detection and assessment system (ICDAS). Participants aged 5-12 years(90%male). Caries prevalence was significantly lower in the ASD group (60%) compared with controls (95%) (p=0.01). DI-S scores indicated fair-to-poor oral hygiene in both groups, with no significant differences. Early ICDAS lesions (codes 1-2) were more common in ASF primary teeth, whereas cavitated lesions (codes 3-6) were more frequent in neurotypical children. In this study population of children with ASD demonstrated lower caries prevalence yet similar biofilm accumulation compared with neurotypical peers.
- 11 July 2025
- Published by Universidad de Costa Rica in Odovtos - International Journal of Dental Sciences
- Vol. 1 (1)
Open AccessEvaluation of Dental Caries Experience and Biofilm Accumulation in Mexican Pediatric Patients with Autism Spectrum Disorder (ADS): A Cross-Sectional Study
Autism Spectrum Disorder (ASD) presents sensory and behavioral challenges that may complicate oral care. This study evaluated biofilm accumulation and caries prevalence in children with and without ASD, enrolled in an educational center in San Luis Potosí, México. A cross-sectional study was conducted at a specialized ASD educational center in San Luis Potosí, México. Twenty children with ASD and 40 neurotypical children, matched by age and sex, underwent oral examinations assessing biofilm using the simplified debris index (DI-S) and caries using the international caries detection and assessment system (ICDAS). Participants aged 5-12 years(90%male). Caries prevalence was significantly lower in the ASD group (60%) compared with controls (95%) (p=0.01). DI-S scores indicated fair-to-poor oral hygiene in both groups, with no significant differences. Early ICDAS lesions (codes 1-2) were more common in ASF primary teeth, whereas cavitated lesions (codes 3-6) were more frequent in neurotypical children. In this study population of children with ASD demonstrated lower caries prevalence yet similar biofilm accumulation compared with neurotypical peers.